NCT05998291|Enrolling By Invitation
Dermatitis Herpetiformis Refractory to Gluten Free Diet
Gluteenittomaan Ruokavaliohoitoon Vastaamaton Ihokeliakia
Loading search results
Gluteenittomaan Ruokavaliohoitoon Vastaamaton Ihokeliakia
Sponsor study identifier
observational
23
1 country
1
Study Start
June 15, 2023
Actual (reported)Primary Completion
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The main purpose of the study is to find out
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2, 2023
Actual (reported)June 15, 2023
Actual (reported)August 18, 2023
Actual (reported)December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Clinical prognosis
Occurrence of complications
Baseline
Dietary adherence GIP test, CDAT, TG2, TG3 and Ema antibodies, anamnesis
Baseline
Microbiata
Baseline
Quality of life measure DLQI
Baseline
Quality of life measure BGWP
Baseline
Dermatitis herpetiformis rash not controlled by strict glute-free diet
Dermatitis herpetiformis rash controlled by strict glute-free diet
Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Adult patients with refractory dermatitis herpetiformis
Tampere University Hospital
Tampere, 33101, Finland
Kaisa Hervonen, PhD
Tampere University Hospital
First Submitted
March 2, 2023
First Posted
August 18, 2023
Study Start
June 15, 2023
Actual (reported)Primary Completion
December 31, 2025
Estimated (date passed)Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
August 22, 2023
Record last verified: 2023-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: